Theranica
Nerivio Acute Migraine Therapeutic Device Is Now Available to Veterans
Nerivio has shown clinical efficacy for episodic and chronic migraine, both in clinical trials and real-world evidence analyses reports Jason Sico, MD, Associate Professor of Neurology and Internal Medicine in Yale School of Medicine.
Nerivio Device for Acute Treatment of Migraine in Adolescents Receives FDA Approval
The use of the device in the treatment of adolescents is supported by a study recently published in Headache.